Non-alcoholic fatty liver disease and insulin resistance: Importance of risk factors and histological spectrum

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 8, 2005, Pages 837-841

  Guidorizzi De Siqueira, Ana Cristina ^a,c   Cotrim, Helma P ^a   Rocha, Raquel ^a   Carvalho, Fernando M ^a   De Freitas, Luiz A R ^a,b   Barreto, Danyella ^a   Gouveia, Leandro ^a   Landeiro, Luciana ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c NONE   (Brazil)

Author keywords

Insulin resistance; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis

Indexed keywords

ADULT; ARTICLE; EXPOSURE; FEMALE; FIBROSIS; HISTOLOGY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MALLORY BODY; MODEL; MORBIDITY; NONALCOHOLIC FATTY LIVER; PETROCHEMICAL INDUSTRY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STAGING; STATISTICAL ANALYSIS; STEATOSIS; WAIST CIRCUMFERENCE;

ADULT; CHRONIC DISEASE; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 23044501638     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200508000-00010     Document Type: Article

References (20)

1. Brunt EM. Nonalcoholic steatohepatitis. Definition and pathology. J Liver Dis 2001; 21:3-14.
2. Caldwell S, Oelsner D, Iezzoni J, Hespenheide E, Battle E, Driscoll C. Cryptogenic cirrhosis. Clinical characterization and risk factors for underlying disease. Hepatology 1999; 29:664-669.
3. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Wed 1997; 126:137-145.
4. Falck-Ytter Y, Younossi Z, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Seminars Liver Dis 2001; 21:17-26.
5. Marchesini G, Bugianesi E, Forlani G, Cerreli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome. Hepatology 2003; 37:917-923.
6. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Non alcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes 2001; 50:1844-1850.
7. Chitturi S, Abeygunasekera S, Farrell G, Holmes-Walker J, Hui J, Fung C, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35:373-378.
8. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, et al. Nonalcoholic steatohepatitis, insulin resistance and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35:367-371.
9. Marchesini G, Bizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107:450-455.
10. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183-1195.
11. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285:2486-2497.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
13. Matteoni C, Younossi Z, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116:1413-1419.
14. Brunt EM, Janney CG, Di Bisceglie AM, Brent A, Neuschwander-Tetri BA, Bacon B. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467-2474.
15. Norussis MJ. Statistical Package for the Social Sciences (SPSS), version 9.0. Chicago, IL: SPSS Inc.; 1998.
16. Cotrim H, Andrade Z, Parana R, Portugal M, Lyra L, Freitas L. Nonalcoholic steatohepatitis: a toxic liver disease in industrial workers. Liver 1999; 19:299-304.
17. Cotrim H, Freitas LAR, Freitas C, Braga L, Sousa R, Carvalho F, et al. Clinical and histopathological features of NASH in workers exposed to chemical with or without associated metabolic conditions. Liver Int 2004; 24:131-135.
18. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000; 118:1117-1123.
19. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30:1356-1362.
20. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994; 19:616-627.